Elsevier

Clinics in Dermatology

Volume 9, Issue 3, July–September 1991, Pages 383-392
Clinics in Dermatology

Linear IgA bullous dermatosis of adults

https://doi.org/10.1016/0738-081X(91)90030-OGet rights and content

First page preview

First page preview
Click to open first page preview

References (87)

  • MA Barnadas et al.

    Linear IgA bullous dermatosis associated with Hodgkin's disease

    J Am Acad Dermatol

    (1988)
  • MT McEvoy et al.

    Linear IgA dermatosis: Association with malignancy

    J Am Acad Dermatol

    (1990)
  • TJ Lawley et al.

    Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA skin deposits

    J Invest Dermatol

    (1980)
  • JD Hendrix et al.

    Cutaneous IgA deposits in bullous disease function as ligands to mediate adherence of activated neutrophils

    J Invest Dermatol

    (1990)
  • JH Schiffner

    Therapy of childhood linear IgA dermatitis herpetiformis

    J Am Acad Dermatol

    (1982)
  • TP Chorzelski et al.

    Linear IgA bullous dermatosis. Adult form of linear IgA bullous dermatotis

  • S Jabłońska et al.

    Dermatitis herpetiformis and bullous pemphigoid. Intermediate and mixed forms

    Arch Dermatol

    (1976)
  • H Pehamberger et al.

    Juvenile dermatitis herpetiformis: An immunoelectron-microscopic study

    Br J Dermatol

    (1979)
  • M Meurer et al.

    Dermatitis herpetiformis Duhring mit lineären Ablagerungen von IgA (lineäre IgA-Dermatose)

    Hautarzt

    (1984)
  • JF Honeyman et al.

    The enigma of bullous pemphigoid and dermatitis herpetiformis

    Arch Dermatol

    (1972)
  • JF Honeyman et al.

    Polymorphic pemphigoid

    Arch Dermatol

    (1979)
  • S Jabłońska et al.

    Überlappungssyndrome bei bullösen Dermatosen

  • J Dab̧rowski et al.

    Immunoelectron microscopic studies in IgA linear dermatitis

    Arch Dermatol Res

    (1979)
  • I Rantala et al.

    Immunoelectron microscopic findings in oral mucosa of patients with dermatitis herpetiformis and linear IgA disease

    Scand J Dent Res

    (1985)
  • B Bhogal et al.

    Linear IgA bullous dermatosis of adults and children: An immunoelectron microscopic study

    Br J Dermatol

    (1987)
  • JN Leonard et al.

    Experience with a gluten free diet in the treatment of linear IgA disease

    Acta Derm Venereol (Stockh)

    (1987)
  • S Jabłońska et al.

    Herpetiformis pemphigus: A variable pattern of pemphigus

    Int J Dermatol

    (1975)
  • H Mobacken et al.

    Linear IgA dermatosis: A study of ten adult patients

    Acta Derm Venereol (Stockh)

    (1983)
  • MF Viet-Porges et al.

    Dermatite à IgA linéaire à localisation cérvicofaciale

    Ann Derm Venereol

    (1987)
  • JH Barth et al.

    Palmo-plantar involvement in auto-immune blistering disorders—Pemphigoid, linear IgA disease and herpes gestationis

    Clin Exp Dermatol

    (1988)
  • A Fuligni et al.

    A peculiar case of linear IgA bullous dermatitis

    Arch Dermatol

    (1991)
  • JN Leonard et al.

    The relationship between linear IgA disease and benign mucous membrane pemphigoid

    Br J Dermatol

    (1984)
  • K Tamaki et al.

    Cicatricial pemphigoid with IgA deposits

    J Dermatol (Tokyo)

    (1990)
  • J Aboobaker et al.

    The localization of the binding site of circulating IgA antibodies in linear IgA disease of adults, chronic bullous disease of childhood and childhood cicatricial pemphigoid

    Br J Dermatol

    (1987)
  • G Leigh et al.

    Linear IgA dermatosis with severe arthralgia

    Br J Dermatol

    (1988)
  • REA Williams

    Linear IgA dermatosis with severe arthralgia

    Br J Dermatol

    (1989)
  • TO Gabrielsen et al.

    Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane

    Acta Derm Venereol (Stockh)

    (1981)
  • JD McWhirter et al.

    Linear IgA bullous dermatosis related to lithium carbonate

    Arch Dermatol

    (1987)
  • L Baden et al.

    Vancomycin-induced linear IgA bullous dermatosis

    Arch Dermatol

    (1988)
  • F Lemarchand-Venencie et al.

    Dermatose bullouse à IgA linéaire au décours immédiat d'une urographie intra-veineuse

    Ann Dermatol Venereol

    (1987)
  • C Bruley et al.

    Dermatose à IgA linéaire photo-aggravée

    Ann Dermatol Venereol

    (1987)
  • Y Thaipisuttikul et al.

    Coexistence of linear IgA dermatitis herpetiformis and systemic lupus erythematosus

    J Dermatol (Tokyo)

    (1983)
  • M Lau et al.

    A case report of a patient with features of systemic lupus erythematosus and linear IgA disease

    Br J Dermatol

    (1991)
  • Cited by (54)

    • Linear IgA bullous dermatosis with desquamative gingivitis: A case report and literature review

      2022, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
      Citation Excerpt :

      These antigens have been shown to be fragments of BP180/collagen XVII. It has been reported that this hemidesmosomal type II transmembrane protein is a key structural component that plays a role in the epidermal-dermal adhesion [24,25]. Guide et al. said that western immunoblotting analysis for the LAD protein in the epidermal extract (97 kDa) or the cultured keratinocyte supernatant (120 kDa) has been shown a more sensitive method than IIF to detect autoantibodies in bullous diseases including LAD[24].

    • Autoimmune blistering diseases

      2014, Revue de Medecine Interne
    • Linear IgA bullous dermatosis: A review

      2011, Annales de Dermatologie et de Venereologie
    • Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies

      2010, Clinics in Dermatology
      Citation Excerpt :

      In BP it can also be used alone with excellent results. In light of our clinical experience and literature data,3-53 the two candidates to reach the finals are azathioprine and mycophenolate mofetil, both of which are more effective and safe than other ISAs. Although mycophenolate mofetil is more expensive than azathioprine, the need for more frequent routine laboratory monitoring, TPMT screening, and potentially more frequent management of adverse effects in azathioprine-treated patients may balance the long-term costs49; however, a comparison of the properties of the different drugs tested led us to conclude that there is no outright winner.

    View all citing articles on Scopus
    View full text